Insomnia | | Disease | Drug | Abatacept (Orencia)- FDA | | | | | | |
Des (1-3) IGF-I | | Target | Target | Des (1-6) IGF-II | | | | | | |
CD4 | | Target | Drug | Abatacept (Orencia)- FDA | | | | | | |
Adalimumab (Humira)- FDA | | Drug | Drug | Abatacept (Orencia)- FDA | | | | | | |
Diarrhea | | Disease | Drug | Abatacept (Orencia)- FDA | | | | | | |
Fracture | | Disease | Target | BMP-2B | | | | | | |
Carcinoma | | Disease | Target | BMP-2B | | | | | | |
Anemia | | Disease | Drug | Abatacept (Orencia)- FDA | | | | | | |
Arthritis | | Disease | Drug | Abatacept (Orencia)- FDA | | | | | | |
Thrombocytopenia | | Disease | Drug | Aldactone (Spironolactone)- FDA | | | | | | |
Infection | | Disease | Drug | Allopurinol (Zyloprim)- FDA | | | | | | |
Influenza | | Disease | Drug | Abatacept (Orencia)- FDA | | | | | | |
Cancer | | Disease | Drug | Abatacept (Orencia)- FDA | | | | | | |
Hepatitis B | | Disease | Drug | Abatacept (Orencia)- FDA | | | | | | |
Infection | | Disease | Drug | Abatacept (Orencia)- FDA | | | | | | |
Diabetes | | Disease | Drug | Abatacept (Orencia)- FDA | | | | | | |
Colon Cancer | | Disease | Drug | Aldactone (Spironolactone)- FDA | | | | | | |
Androgen Receptor | | Target | Drug | Aldactone (Spironolactone)- FDA | | | | | | |
Lung Cancer | | Disease | Disease | Carcinoma Brain | | | | | | |
Cancer | | Disease | Target | BMP-2B | | | | | | |
Tuberculosis | | Disease | Drug | Abatacept (Orencia)- FDA | | | | | | |
Headache | | Disease | Drug | Abatacept (Orencia)- FDA | | | | | | |
Prostate Cancer | | Disease | Drug | Abatacept (Orencia)- FDA | | | | | | |
Chagas Disease | | Disease | Drug | Allopurinol (Zyloprim)- FDA | | | | | | |
Organ Transplantation | | Disease | Drug | Abatacept (Orencia)- FDA | | | | | | |
Androgen Receptor | | Target | Target | BMP-2B | | | | | | |
Arava (Leflunomide)- FDA | | Drug | Drug | Abatacept (Orencia)- FDA | | | | | | |
Diabetes | | Disease | Drug | Aldactone (Spironolactone)- FDA | | | | | | |
Joint Pain | | Disease | Drug | Abatacept (Orencia)- FDA | | | | | | |
Seizure | | Disease | Drug | Allopurinol (Zyloprim)- FDA | | | | | | |
ERK1 | | Target | Target | beta-Cellulin | | | | | | |
Epigen | | Target | Target | beta-Cellulin | | | | | | |
ERBB3 | | Target | Target | beta-Cellulin | | | | | | |
Infection | | Disease | Drug | Avonex (Interferon beta-1a)- FDA | | | | | | |
Cancer | | Disease | Target | beta-Cellulin | | | | | | |
Breast Cancer | | Disease | Target | beta-Cellulin | | | | | | |
Cancer | | Disease | Target | Vitamin D Receptor Interacting Protein | | | | | | |
Glucocorticoid Receptor | | Target | Target | Vitamin D Receptor Interacting Protein | | | | | | |
Lung Cancer | | Disease | Target | beta-Cellulin | | | | | | |
Lung Cancer | | Disease | Target | beta-Cellulin | | | | | | |
Prostate Cancer | | Disease | Target | beta-Cellulin | | | | | | |
Alemtuzumab (Campath)- FDA | | Drug | Drug | Avonex (Interferon beta-1a)- FDA | | | | | | |
Non Small Cell Lung Cancer | | Disease | Target | beta-Cellulin | | | | | | |
Obesity | | Disease | Target | beta-Cellulin | | | | | | |
EGF | | Target | Target | beta-Cellulin | | | | | | |
ERBB4 | | Target | Target | beta-Cellulin | | | | | | |
Renal Failure | | Disease | Drug | Avonex (Interferon beta-1a)- FDA | | | | | | |
Epidermal Growth Factor Receptor | | Target | Target | beta-Cellulin | | | | | | |
Endostatin | | Target | Target | Angiostatin K1-3 | | | | | | |
Erbb2 | | Target | Target | beta-Cellulin | | | | | | |